METHYL 4-(TERT-BUTOXYCARBONYLAMINO)CYCLOHEXANECARBOXYLATE, 95.0%, 250mg

2,3-Difluoro-4-(trifluoromethyl)benzeneboronic acid, 96%, 1g

2-(3-Hydroxytetrahydrofuran-3-yl)acetic acid, 98%, 1g

1-(3,3,3-Trifluoropropyl)-1H-pyrazole-5-carboxylic acid, 98%, 100mg

3-Methoxybenzoyl chloride, 95.0%, 5g

Dimethyl Isophthalate>99.0%(GC)25g

2-(p-Toluenesulfonyl)ethanol, 98.0%, 25g

tert-Butyl 4-allyl-4-hydroxypiperidine-1-carboxylate, 95.0%, 1g

2-Chloro-4,7-difluorobenzo[d]thiazole, 95.0%, 50mg

4-(4-methylbenzoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

Tris(trimethylsilyl)silane [Reducing Reagent]>90.0%(GC)25mL

1,2,3,4,5,6-Hexahydrobenzo[b][1,5]diazocine, 97.0%, 5g

Fase de plan de larga distancia de trabajo Contraste Fluarex 20x/0,45 Objetivo IOS corregido al infinito, corregido para un espesor de placa de Petri de 1 mm